Clinical trials
Stomach Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 7 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Terminated | 18 |
| Active, not recruiting | 13 |
| Recruiting | 11 |
| Unknown status | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 6 |
| Hoffmann-La Roche | 5 |
| Novartis Pharmaceuticals | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Daiichi Sankyo | 3 |
| KU Leuven | 3 |
| Sanofi | 3 |
| Taiho Oncology, Inc. | 3 |
| AstraZeneca | 2 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 78 |
| Colorectal Neoplasms | 15 |
| Esophageal Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Ovarian Neoplasms | 10 |
| Pancreatic Neoplasms | 9 |
| Neoplasms | 8 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Breast Neoplasms | 7 |
| Melanoma | 7 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.